• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转入地下:为自然主义迷幻药使用提供支持的从业者认可的人口统计学、服务及最佳实践

Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.

作者信息

Glynos Nicolas G, Baker Anne, Aday Jacob S, Pouyan Niloufar, Barron Julie, Herberholz Moss, Kruger Daniel, Boehnke Kevin F

机构信息

Anesthesiology Department, University of Michigan Medical School, Ann Arbor, MI, USA.

Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

J Psychoactive Drugs. 2024 Sep 19:1-11. doi: 10.1080/02791072.2024.2405685.

DOI:10.1080/02791072.2024.2405685
PMID:39297183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11919790/
Abstract

Psychedelic-assisted therapy (PAT) has shown preliminary efficacy for psychiatric and physical health conditions. Although some people report naturalistic psychedelic use with so-called "underground" practitioners, little is known about PAT that occurs outside of controlled clinical settings or perspectives of these practitioners. We conducted an anonymous online survey of individuals who reported providing psychedelic support services (e.g. trip sitting and/or preparatory/follow-up psychotherapy) in naturalistic settings. We investigated demographics, including education and licensing, details about services provided, and reported client outcomes. Among 107 participants, 40.2% held a full or in-progress license and 44.9% had not obtained a relevant graduate degree. Almost all participants reported pre-screening clients before treatment, offering preparation, integration, and trip-sitting services, and most employed a range of therapeutic modalities, centering primarily on non-directive approaches. Participants reported that clients most commonly consumed psilocybin, and treated numerous conditions, primarily aligning with indications targeted in psychedelic clinical research. Perceptions of clients' symptom changes were largely positive, although a small proportion reported worsened personality disorder symptoms. Further research delineating client and practitioner perspectives of naturalistic PAT services is warranted, and such work may shed light on the benefits and risks specific to naturalistic PAT as well as inform best practices for practitioners.

摘要

迷幻辅助疗法(PAT)已显示出对精神和身体健康状况的初步疗效。尽管有些人报告称在所谓的“地下”从业者那里有非正规使用迷幻剂的情况,但对于在受控临床环境之外进行的PAT或这些从业者的观点却知之甚少。我们对那些报告在自然环境中提供迷幻支持服务(如陪伴旅程和/或准备/后续心理治疗)的个人进行了一项匿名在线调查。我们调查了人口统计学特征,包括教育程度和执照情况、所提供服务的细节以及报告的客户治疗结果。在107名参与者中,40.2%持有完整或正在获取的执照,44.9%没有获得相关的研究生学位。几乎所有参与者都报告在治疗前对客户进行了预筛查,提供准备、整合和陪伴旅程服务,并且大多数人采用了一系列治疗方式,主要以非指导性方法为核心。参与者报告说客户最常使用裸盖菇素,治疗了多种病症,主要与迷幻剂临床研究针对的适应症相符。对客户症状变化的看法大多是积极的,尽管有一小部分人报告人格障碍症状恶化。有必要进一步研究以明确自然环境下PAT服务中客户和从业者的观点,这样的工作可能会揭示自然环境下PAT特有的益处和风险,并为从业者提供最佳实践参考。

相似文献

1
Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use.转入地下:为自然主义迷幻药使用提供支持的从业者认可的人口统计学、服务及最佳实践
J Psychoactive Drugs. 2024 Sep 19:1-11. doi: 10.1080/02791072.2024.2405685.
2
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.探索运动员使用迷幻剂的情况及其对裸盖菇素辅助治疗脑震荡恢复的态度。
Ther Adv Psychopharmacol. 2024 Aug 7;14:20451253241264812. doi: 10.1177/20451253241264812. eCollection 2024.
3
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
4
Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.将迷幻辅助疗法从有前途的研究推向常规临床实践:来自实施科学领域的经验教训。
Transl Behav Med. 2024 Nov 25;14(12):744-752. doi: 10.1093/tbm/ibae053.
5
Racial Differences in Naturalistic Psychedelic Use - Motivations for Use, Communication with Health Care Providers, and Outcomes.自然主义迷幻药使用中的种族差异——使用动机、与医疗保健提供者的沟通及结果
J Psychoactive Drugs. 2025 Apr 22:1-12. doi: 10.1080/02791072.2025.2491381.
6
Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers.迈向参与的萎靡姿态:自然使用迷幻剂的人与他们的医疗服务提供者之间的互动。
Front Psychiatry. 2023 Aug 4;14:1224551. doi: 10.3389/fpsyt.2023.1224551. eCollection 2023.
7
Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.迷幻剂与心理治疗:以认知行为疗法为常规方法
Front Psychol. 2022 May 23;13:873279. doi: 10.3389/fpsyg.2022.873279. eCollection 2022.
8
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.迷幻剂临床试验报告实践的系统评价:心理支持、治疗与社会心理干预
Psychedelic Med (New Rochelle). 2023 Dec 13;1(4):218-229. doi: 10.1089/psymed.2023.0007. eCollection 2023 Dec.
9
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.自然使用迷幻剂后大麻、阿片类药物和兴奋剂滥用情况持续减少:一项在线调查。
Front Psychiatry. 2020 Jan 22;10:955. doi: 10.3389/fpsyt.2019.00955. eCollection 2019.
10
Beyond the numbers: reimagining healing with psychedelics for eating disorders.数字之外:重新构想用迷幻药治疗饮食失调症
J Eat Disord. 2024 Sep 30;12(1):148. doi: 10.1186/s40337-024-01111-y.

本文引用的文献

1
Psychedelic-assisted psychotherapy: where is the psychotherapy research?迷幻辅助心理治疗:心理治疗研究在哪里?
Psychopharmacology (Berl). 2024 Aug;241(8):1517-1526. doi: 10.1007/s00213-024-06620-x. Epub 2024 May 24.
2
Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research.在摇头丸辅助治疗研究中,期望效应不容忽视。
ACS Chem Neurosci. 2023 Dec 6;14(23):4062-4063. doi: 10.1021/acschemneuro.3c00692. Epub 2023 Nov 15.
3
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.MDMA 辅助治疗中重度 PTSD:一项随机、安慰剂对照的 3 期试验。
Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14.
4
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.单剂量裸盖菇素治疗重度抑郁症:一项随机临床试验。
JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530.
5
The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada.加拿大自然主义致幻剂使用与临床护理的关系。
J Psychoactive Drugs. 2023 Nov-Dec;55(5):660-671. doi: 10.1080/02791072.2023.2242353. Epub 2023 Jul 29.
6
Therapeutic mechanisms of psychedelics and entactogens.迷幻剂和快感增强剂的治疗机制。
Neuropsychopharmacology. 2024 Jan;49(1):104-118. doi: 10.1038/s41386-023-01666-5. Epub 2023 Jul 24.
7
Emerging Challenges for Psychedelic Therapy.迷幻疗法面临的新挑战。
JAMA Psychiatry. 2023 Jun 1;80(6):533-534. doi: 10.1001/jamapsychiatry.2023.0549.
8
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.单次剂量裸盖菇素治疗难治性重度抑郁症发作。
N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443.
9
Applying Lessons From Cannabis to the Psychedelic Highway: Buckle Up and Build Infrastructure.将大麻的经验教训应用于迷幻药发展之路:系好安全带,构建基础设施。
JAMA Health Forum. 2022 Jun 3;3(6):e221618. doi: 10.1001/jamahealthforum.2022.1618.
10
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.一项受研究领域标准(RDoC)指导的审查裸盖菇素作用靶域的仪表盘:系统评价。
CNS Drugs. 2022 Oct;36(10):1031-1047. doi: 10.1007/s40263-022-00944-y. Epub 2022 Sep 12.